RBC Lysis Buffer (10X) and 4 more items

BioLegend Inc. was awarded contract A207_PO-0465173 by the University of Virginia on August 4, 2026, with a cumulative contract value of $1,143.15. The contract encompasses the delivery of specialized laboratory reagents and monoclonal antibodies to Melissa A. Marshall at the University of Virginia in Virginia. The deliverables consist of five distinct line items comprising flow cytometry reagents and antibody products essential for immunological research applications.

The contract includes four units of RBC Lysis Buffer (10X) at $45.50 per unit, one unit of Brilliant Violet 421a anti-mouse CD185 (CXCR5) monoclonal antibody at $309.75, one unit of Brilliant Violet 570a anti-mouse CD62L antibody at $153.00, two units of PE/Fire 810 anti-mouse CD279 (PD-1) antibody at $119.70 per unit, and one unit of Spark Blue 550 anti-mouse CD8a antibody at $259.00. These reagents are commonly utilized in flow cytometric analysis for murine immunology research, including T-cell phenotyping and immune checkpoint characterization. No annual value or specific contract performance period was identified in the award documentation.